Skip to main content

Month: April 2023

BrewBilt Manufacturing Hits $350K in 1st Qtr -2023 Sales With $1M Deferred Sales for 2nd Qtr and Installs Dorcol Distilling & Brewing Co in Texas This Week

GRASS VALLEY, CA, April 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Today BrewBilt Manufacturing Inc. (the “Company”) (OTCPINK: BBRW) announced the new installation of a 15BBL brewhouse in San Antonio Texas for Dorcol Distilling & Brewing Co.; the makers of fine spirits, craft cocktails and artisan ales known as Kinsman Rakia and Highwheel. BrewBilt Manufacturing sales for the first quarter ending March 31, 2023 is approximately $350,000, with over $1M of deferred revenue which are for jobs to be delivered in the second quarter ending June 30, 2023.  DORCOL received a Critics’ Choice Award for Best Locally Made Spirit/Beer, and Kinsman Apricot Rakia was named the 2014 highest rated American brandy at the Beverage Testing Institute’s World Spirit Championships in Chicago. The 90-point Gold medal also tied the...

Continue reading

Beam Global Receives Order from Top Global Automotive Manufacturer for Solar-Powered EV ARC™ Electric Vehicle Charging Systems

Deploy 100% renewably powered EV charging in minutes, not months. The EV ARC solar EV charger is off-grid, transportable, and deploys with no construction, no electrical work and no utility bill.SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy storage, energy security and outdoor media, announced a leading global automotive brand has placed an order for EV ARC™ solar-powered EV charging systems. “Receiving an order from a global, name-brand, automotive manufacturer is both a further validation of our products’ capabilities and a continued indication of the mainstream adoption of our technology,” said Beam Global CEO Desmond Wheatley. “While we cannot disclose...

Continue reading

Platinex Secures Dominant Land Position at W2 with Claim Acquisitions

Platinex W2 Project Claim MapTORONTO, April 18, 2023 (GLOBE NEWSWIRE) — Platinex Inc. (CSE:PTX) (Frankfurt: 9PX) (“Platinex” or the “Company“) is pleased to announce that its wholly owned subsidiary, Endurance Elements Inc. (“Endurance Elements”) has expanded its W2 Copper-Nickel-PGE and Gold Project (the “W2 Project” or “W2”) near Ontario’s Ring of Fire by acquiring 225 additional single-cell mining claims. The total land package at W2 now comprises 1,122 cell units covering 22,094 ha (220 km2). Notably, Barrick Gold has recently taken on a large land position in the immediate W2 area, staking 1,198 single-cell mining claims covering 23,565 hectares (235.65 square km2) of ground adjacent to blocks held by Endurance Elements (see claim map in Figure 1). Since the acquisition of W2 in January 2022 –...

Continue reading

SMG Industries, Inc. Announces Fiscal Year 2022 Earnings and Record Revenues for 2022

SMG Reports Record Revenues of $71 Million for Fiscal Year ended December 31, 2022, an Increase of 36% From 2021 Revenues, and a 2022 Positive Adjusted EBITDA of $4.8 Million HOUSTON, TX, April 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – SMG Industries, Inc. (“SMG” or the “Company”) (OTCQB:SMGI), a growth-oriented transportation services company focused on the domestic infrastructure logistics market, today announced that its audited results of consolidated revenues from operations for the year ended December 31, 2022 was a record $71,021,862, representing an increase of 36% from $52,113,827 reported for the year ended December 31, 2021. For the year ended December 31, 2022, Adjusted EBITDA, a non-GAAP measure, was a positive $4.8 million compared to a loss in the year ago period showing the significant progress...

Continue reading

OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel

Based on large multi-center study with over 1,800 patient samples Primary endpoint for Unyvero UTI for urinary tract infection was successfully met and shows overall weighted average sensitivity of 96.8% and overall weighted average specificity of 97.4% Submission follows FDA’s De Novo pathway for novel medical devicesROCKVILLE, Md., April 18, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, today announced that it has submitted a De Novo classification request to the U.S. Food and Drug Administration (FDA) seeking marketing authorization for its Unyvero UTI Urinary Tract Infection (UTI) panel, following successful completion of its clinical trial. OpGen’s Unyvero UTI...

Continue reading

Jushi Announces Support and Appreciation for Virginia’s Passage of Medical Cannabis and Cannabinoid Product-Related Bills

BOCA RATON, Fla., April 18, 2023 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced support and appreciation for the Virginia General Assembly’s passage of medical cannabis and cannabinoid product-related bills amended by Governor Glenn Youngkin. Last week, the Virginia General Assembly gathered to take up seventy-eight (78) bills amended by the Governor, including medical cannabis bills designed to enhance program accessibility for patients, improve operational efficiency for pharmaceutical processors and fully transfer regulatory oversight to the Virginia Cannabis Control Authority (“CCA”). Most patient-focused and operations-based changes will become effective on July 1, 2023, and CCA will take over regulating the program...

Continue reading

Commercial Drones Market Size to Hit USD 47.38 Bn by 2029 | With a 28.58% CAGR

The global commercial drone market covered major segments by By Weight ( Pune, India, April 18, 2023 (GLOBE NEWSWIRE) — The global commercial drone market size was valued at USD 6.51 billion in 2021 and is projected to grow from USD 8.15 billion in 2022 to USD 47.38 billion by 2029, exhibiting a CAGR of 28.58% during the forecast period. A commercial drone is an unmanned aerial vehicle (UAV) that is designed for business purposes, such as aerial photography, mapping, surveying, and delivery services. These drones are equipped with high-resolution cameras, GPS navigation systems, and other advanced technologies that enable them to perform a wide range of tasks with precision and efficiency. Commercial drones have gained popularity in recent years, as they offer numerous benefits to businesses, including cost savings, improved safety,...

Continue reading

Aircraft Health Monitoring System Market to Hit USD 4,987.9 Million by 2027 | At a 11.56% CAGR

The global aircraft health monitoring system market covered major segments By Sub-System (Aero-Propulsion System, Airframe, Ancillary System, Software, And Others), By Technology (Prognostic Systems, Diagnostic Systems, Detection Systems, Adaptive Control, And Others), By Platform (Commercial Aircraft, Business Jets, Regional and Military Aircraft), By Fit (Retrofit, and line-fit) and Regional Forecast. Pune, India, April 18, 2023 (GLOBE NEWSWIRE) — The global aircraft health monitoring system market size was USD 4,202.4 million in 2019 and is projected to grow from USD 2,319.7 million in 2020 to USD 4,987.9 million in 2027 at a CAGR of 11.56% in the 2020-2027 period. The Aircraft Health Monitoring System (AHMS) Market is experiencing significant growth, driven by the increasing demand for real-time data analysis and predictive...

Continue reading

Arch Biopartners Announces Positive Results of Dose Escalation Human Trial for LSALT Peptide

TORONTO, April 18, 2023 (GLOBE NEWSWIRE) — Today, Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company focused on the development of novel therapeutics targeting organ inflammation, announced that it has safely increased the maximum daily dose of LSALT peptide to 20 mg per day in healthy, normal volunteers in a recently completed human trial in Australia. LSALT peptide is the Company’s lead drug candidate for treating inflammation in the lungs, liver and kidneys and Arch intends to use the new maximum dose in designing a Phase II trial targeting cardiac surgery-associated acute kidney injury (CS-AKI). The new safety data will be included in an Investigational New Drug Application to the U.S. FDA, to be submitted in relation to the CS-AKI trial in due course. Prior to this...

Continue reading

Hair Care Market to Hit USD 112.97 Billion by 2028 | With a CAGR 5.6%

The global hair care market covered major segments by Product (Hair Colorants, Shampoo, Conditioner, Hair Oil, and Others), by Distribution Channel (Supermarket/Hypermarket, Specialty Stores, Online Stores, and Others), and region. Pune, India, April 18, 2023 (GLOBE NEWSWIRE) — The global hair care market size was valued at USD 75.06 billion in 2020 and is projected to grow from USD 77.15 billion in 2021 to USD 112.97 billion by 2028, exhibiting a CAGR of 5.6% during the forecast period. Factors such as the increasing cases of hair loss among men, coupled with the prevalence of several hair-related ailments, are anticipated to boost the adoption of the product globally. According to a study published in the Journal of Clinical and Diagnostic Research in 2018, 60.3% of working-class males suffer from hair loss problems, while 17.1%...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.